Sat.Sep 17, 2022

article thumbnail

Bluebird wins FDA approval of gene therapy for rare brain disorder

Bio Pharma Dive

The therapy, called Skysona and cleared to treat cerebral adrenoleukodystrophy, is the product of more than a decade of work by Bluebird. It will cost $3 million.

article thumbnail

Opinion: With abortion bans on the rise, kids need to know more about menstruation

NPR Health - Shots

Today, even one missed period could have serious implications for a young person's life. But how late is late, and when is pain or a heavy period a medical concern? Many preteens don't know.

129
129
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent for Eyepoint Pharms drug DEXYCU KIT

Drug Patent Watch

Annual Drug Patent Expirations for DEXYCU+KIT Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one NDA. There are six patents protecting this drug. This drug…. The post New patent for Eyepoint Pharms drug DEXYCU KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

The number of hungry people has doubled in 10 countries. A new report explains why

NPR Health - Shots

The charity Oxfam has issued a new report on hunger and climate change. In countries most severely affected, the number of people experiencing acute hunger has doubled in just 6 years.

115
115
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

New patent expiration for Novo Nordisk drug VAGIFEM

Drug Patent Watch

Annual Drug Patent Expirations for VAGIFEM Vagifem is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Novo Nordisk drug VAGIFEM appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Omicron boosters find few takers

NPR Health - Shots

How has the rollout of the new COVID-19 vaccine boosters gone so far? Shots are plentiful, waits are short, but demand is uncertain.

More Trending

article thumbnail

New patent for Heron Theraps drug ZYNRELEF KIT

Drug Patent Watch

Annual Drug Patent Expirations for ZYNRELEF+KIT Zynrelef Kit is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Heron Theraps drug ZYNRELEF KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent for Deciphera Pharms drug QINLOCK

Drug Patent Watch

Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are seven patents protecting this drug. This drug has…. The post New patent for Deciphera Pharms drug QINLOCK appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Which drugs have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have the most supplementary protection certificates? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52